Literature DB >> 788529

Negative effects of melatonin on depression.

J S Carman, R M Post, R Buswell, F K Goodwin.   

Abstract

In order to test the efficacy of the pineal neurohumor melatonin on depression, the hormone was administered in varying doses to six moderately to severely depressed patients and two patients with Huntington's chorea in double-blind crossover study. Melatonin exacerbated symptoms of dysphoria in these patients, as well as causing a loss of sleep and weight and a drop in oral temperature. Melatonin increased cerebrospinal fluid 5-hydroxyindoleacetic acid and calcium in three of four patients studied. The authors discuss the implications of this finding.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 788529     DOI: 10.1176/ajp.133.10.1181

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

Review 1.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

2.  Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response.

Authors:  Mmalebuso L Mokoena; Brian H Harvey; Francois Viljoen; Susanna M Ellis; Christiaan B Brink
Journal:  Psychopharmacology (Berl)       Date:  2015-04-17       Impact factor: 4.530

3.  Melatonin modulates apomorphine-induced rotational behaviour.

Authors:  S Burton; S Daya; B Potgieter
Journal:  Experientia       Date:  1991-05-15

4.  Melatonin Augments the Effects of Fluoxetine on Depression-Like Behavior and Hippocampal BDNF-TrkB Signaling.

Authors:  Kun Li; Si Shen; Yu-Tian Ji; Xu-Yun Li; Li-San Zhang; Xiao-Dong Wang
Journal:  Neurosci Bull       Date:  2017-10-31       Impact factor: 5.203

Review 5.  Hormone treatment of depression.

Authors:  Russell T Joffe
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 6.  Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors:  Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

7.  Antidepressant effect of 5-methoxypsoralen: a preliminary report.

Authors:  E Souêtre; E Salvati; J L Belugou; P Robert; G Brunet; G Darcourt
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 8.  Insomnia in patients with depression: some pathophysiological and treatment considerations.

Authors:  Ripu D Jindal
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 9.  The relevance of melatonin to sports medicine and science.

Authors:  Greg Atkinson; Barry Drust; Thomas Reilly; Jim Waterhouse
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

10.  Somatic, positive and negative domains of the Center for Epidemiological Studies Depression (CES-D) scale: a meta-analysis of genome-wide association studies.

Authors:  A Demirkan; J Lahti; N Direk; A Viktorin; K L Lunetta; A Terracciano; M A Nalls; T Tanaka; K Hek; M Fornage; J Wellmann; M C Cornelis; H M Ollila; L Yu; J A Smith; L C Pilling; A Isaacs; A Palotie; W V Zhuang; A Zonderman; J D Faul; A Sutin; O Meirelles; A Mulas; A Hofman; A Uitterlinden; F Rivadeneira; M Perola; W Zhao; V Salomaa; K Yaffe; A I Luik; Y Liu; J Ding; P Lichtenstein; M Landén; E Widen; D R Weir; D J Llewellyn; A Murray; S L R Kardia; J G Eriksson; K Koenen; P K E Magnusson; L Ferrucci; T H Mosley; F Cucca; B A Oostra; D A Bennett; T Paunio; K Berger; T B Harris; N L Pedersen; J M Murabito; H Tiemeier; C M van Duijn; K Räikkönen
Journal:  Psychol Med       Date:  2016-03-21       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.